Hyperbaric Oxygen Therapy (HBOT)
Sponsors
Assaf-Harofeh Medical Center, Hendry Irawan, NYU Langone Health, Legacy Health System, Charite University, Berlin, Germany
Conditions
COVID-19Chronic Neurological DeficiencyCovid19Diabetic Foot UlcerHyperbaric Oxygen TherapyInterstitial Cystitis/Bladder Pain SyndromeNeurologic DeficiencyOsteonecrosis of the Femoral Head
Unknown Phase
Hyperbaric Oxygen Therapy Induced Neuroplasticity in Post Stroke Patients Suffering Chronic Neurological Deficiencies
CompletedNCT00715897
Start: 2008-08-31End: 2011-11-30Updated: 2011-12-26
The Effect of Hyperbaric Oxygen Therapy on Patients Suffering From Neurologic Deficiency Due Traumatic Brain Injury
CompletedNCT00715052
Start: 2008-08-31Target: 60Updated: 2013-05-07
Short Duration Hyperbaric Oxygen Therapy to Improve HbA1c, Leukocyte, and Serum Creatinine
CompletedNCT03615755
Start: 2016-12-27End: 2017-03-31Updated: 2020-05-04
Hyperbaric Oxygen for COVID-19 Patients
TerminatedNCT04332081
Start: 2020-04-06End: 2020-05-29Updated: 2021-06-22
Hyperbaric Oxygen for COVID-19 Patients With Moderate to Severe Hypoxemia
TerminatedNCT04619719
Start: 2021-03-15End: 2023-02-09Updated: 2023-03-09
Hyperbaric High Pressure Oxygen Therapy in Post-COVID Syndrome and ME/CFS
CompletedNCT06118138
Start: 2023-07-15End: 2025-12-31Updated: 2026-04-15
SNM vs. HBOT for Refractory IC/BPS
CompletedNCT07091266
Start: 2021-02-01End: 2022-12-31Updated: 2025-07-29
Hyperbaric Oxygen Therapy for Treatment of Severe Radiation-Induced Complications
CompletedNCT07422168
Start: 2016-05-19End: 2019-12-31Updated: 2026-02-19
Triple-Modal Therapy in Early-Stage Femoral Head Osteonecrosis (TM-ONFH)
CompletedNCT07560163
Start: 2025-01-22End: 2025-11-22Updated: 2026-05-06